Open AccessAre Hemodynamics Surrogate End Points in Pulmonary Arterial Hypertension?
Author(s) -
Corey E. Ventetuolo,
Nicole B. Gabler,
J.S. Fritz,
K. Akaya Smith,
Harold I. Palevsky,
James R. Klinger,
Scott D. Halpern,
Steven M. Kawut
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.009690
Subject(s) - medicine , hemodynamics , cardiology , pulmonary hypertension , surrogate endpoint
Although frequently assessed in trials and clinical practice, hemodynamic response to therapy has never been validated as a surrogate end point for clinical events in pulmonary arterial hypertension (PAH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom